Registered number
16160352
Hope Pharma Ltd
Filleted Accounts
31 January 2026

Hope Pharma Ltd
Registered number: | 16160352
Balance Sheet
as at 31 January 2026
Notes |  |  | 2026 |
£ |
Fixed assets
Tangible assets | 3 |  |  | 1,500
Current assets
Debtors | 4 |  | 8,053
Cash at bank and in hand |  |  | 19,551
|  |  | 27,604 |  |
Creditors: amounts falling due within one year | 5 |  | (13,519)
Net current assets |  |  |  | 14,085 |
Net assets |  |  |  | 15,585 |
Capital and reserves
Called up share capital |  |  |  | 2
Profit and loss account |  |  |  | 15,583
Shareholder's funds |  |  |  | 15,585 |
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mohammad Salem
Director
Approved by the board on 1 February 2026

Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts . Turnover includes revenue earned from the rendering of locum pharmacy services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery | over 5 years
Fixtures, fittings, tools and equipment | over 5 years
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
Employees | 2026 |
Number |
Average number of persons employed by the company | 1
Tangible fixed assets
|  |  |  |  |  |  | Office Equipment
£
Cost
Additions | 2,000
At 31 January 2026 | 2,000
Depreciation
Charge for the period | 500
At 31 January 2026 | 500
Net book value
At 31 January 2026 | 1,500
At 1 January 2025 | 2,000
Debtors | 2026 |
£ |
Other debtors | 8,053
Creditors: amounts falling due within one year | 2026 |
£ |
Taxation and social security costs | 12,770
Accruals and deferred income | 749
|  |  |  |  | 13,519 |
Other information
Hope Pharma Ltd is a private company limited by shares and incorporated in England. Its registered office is:
71-75, Shelton Street
Covent Garden
London
WC2H 9JQ

Hope Pharma Ltd 16160352 false 2025-01-02 2026-01-31 2026-01-31 VT Final Accounts November 2025 Mohammad Salem No description of principal activity 16160352 2025-01-02 2026-01-31 16160352 bus:PrivateLimitedCompanyLtd 2025-01-02 2026-01-31 16160352 bus:AuditExemptWithAccountantsReport 2025-01-02 2026-01-31 16160352 bus:Director40 2025-01-02 2026-01-31 16160352 1 2025-01-02 2026-01-31 16160352 2 2025-01-02 2026-01-31 16160352 countries:England 2025-01-02 2026-01-31 16160352 bus:FRS102 2025-01-02 2026-01-31 16160352 bus:FilletedAccounts 2025-01-02 2026-01-31 16160352 2026-01-31 16160352 core:WithinOneYear 2026-01-31 16160352 core:ShareCapital 2026-01-31 16160352 core:RetainedEarningsAccumulatedLosses 2026-01-31 16160352 2025-01-01 iso4217:GBP xbrli:pure